Form 8-K - Current report:
SEC Accession No. 0001640334-24-001915
Filing Date
2024-12-20
Accepted
2024-12-20 16:45:14
Documents
15
Period of Report
2024-12-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm   iXBRL 8-K 29253
  Complete submission text file 0001640334-24-001915.txt   156071

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA artl-20241220.xsd EX-101.SCH 5874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20241220_lab.xml EX-101.LAB 15188
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20241220_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20241220_pre.xml EX-101.PRE 9628
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20241220_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT artl_8k_htm.xml XML 4021
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 241568564
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)